Feb 19
|
Radiance Biopharma Enters Exclusive License For ROR-1 Targeted Antibody Drug Conjugate
|
Feb 18
|
February 2025 Penny Stocks Worth Watching
|
Oct 8
|
AstraZeneca Inks Agreement to Boost Cardiovascular Pipeline
|
Oct 7
|
AstraZeneca Inks $1.92B License Pact With Hong Kong-Based Firm To Boost Cardiovascular Pipeline
|